Vitamin D Toxicity

Vitamin D Supplementation for the Prevention of Rickets and Osteomalacia
 400 IU/day (10µg) is adequate to prevent rickets and is recommended for all infants from birth to 12 months of age, independent of their mode of feeding (1)
 Beyond 12 months of age, all children and adults need to meet their nutritional requirement for vitamin D through diet and/or supplementation, which is at least 600 IU/day (15µg), as recommended by the Institutes of Medicine (IOM) (1).
Target for Vitamin D Supplementation
 In healthy children, routine 25OHD screening is not recommended and consequently, no specific 25OHD threshold for vitamin D supplementation is targeted in this population.
(1)
Candidates for Preventative Vitamin D Supplementation beyond 12 months of age
In the absence of food fortification, Vitamin D supplementation should be given to:
 Children with a history of symptomatic vitamin D deficiency requiring treatment.  There is little evidence that maternal supplementation with vitamin D will protect or improve birth anthropometry (2) and no evidence that supplementation with vitamin D will protect or improve short-or long-term growth or bone mass accretion (2). 
(1)

The Effect of Calcium Supplementation during Pregnancy on Infant Bone Mass
Introduction
Nutritional rickets (NR), secondary to vitamin D deficiency and/or dietary calcium deficiency, remains a significant global, public health problem despite the availability of supplementation and numerous, published guidelines for its prevention. [1] [2] [3] [4] [5] [6] [7] [8] This is concerning, since NR can have a major impact on the health of infants, children and adolescents, with ramifications that persist into adulthood. The morbidity and mortality associated with NR can be devastating with substantial but poorly recognized consequences for society and health economics. Features of NR and osteomalacia include 1) hypocalcaemic seizures and tetanic spasms, 2) life-threatening hypocalcaemic cardiomyopathy, 3) bone pain and muscle weakness, 4) limb and pelvic deformities, 5) failure to thrive, 6) developmental delay and 7) dental anomalies. 9, 10 Alarmingly, NR can also lead to death from heart failure caused by hypocalcaemic cardiomyopathy even in developed countries. 11 In addition, narrowing of the pelvic outlet following NR in childhood can result in obstructed labour and maternal and fetal death.
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Despite intense focus around the role of vitamin D status in health and disease, there has been world-wide failure to implement public health guidance and eradicate the most severe manifestations of vitamin D and calcium deficiency in our most vulnerable population -rickets and osteomalacia of childhood.
Therefore, the goal of this consensus statement is to provide clinicians with clarity and recommendations on the recognition, societal burden and treatment of NR and osteomalacia, and to enable clinicians and health policy leaders to establish appropriate clinical and public health interventions to prevent this debilitating, costly and under-recognized global health problem.
Methods
In recognition of the considerable variation in its definition, diagnosis and management of NR worldwide, America, Asia, Africa and Australia, with a balanced spectrum of professional seniority and expertise. In addition, an expert on the development of evidence-based guidelines served in an advisory capacity. Panel members declared any potential conflict of interest at the initial meeting of the group. Thirty-three participants were assigned to one of five groups to which topics 1-5 were allocated, and a chairperson was designated for each group. Each participant prepared an evidence-based summary of the literature relating to a particular question distributed before the conference (which was held over 3 days in May 2014).
Each group presented the revised summaries for discussion to the full conference. This report is based on the questions addressed. A detailed description of the GRADE classification has been published elsewhere. 13 Recommendations were based on published findings and on expert opinion when appropriate.
The best available research evidence was used to develop recommendations. Preference was given to articles written in English, identified by PubMed searches with MeSH terms. For each point, recommendations and evidence are described, with a modification in the grading evidence as follows: 1 = strong recommendation (applies to most patients in most circumstances, benefits clearly outweigh the risk); and 2 = weak recommendation (consensus opinion of working group or should be considered; the best action may depend on circumstances or patient values, benefits, and risks closely balanced or uncertain). Quality of evidence is indicated as follows: , high quality (prospective cohort studies or randomized controlled trials (RCT) at low risk of bias); , moderate quality (observational studies or trials with methodological flaws, inconsistent or indirect evidence); and , low quality (case series or non-systematic clinical observations). 13 The target audience for these guidelines includes general and specialist pediatricians, other professionals providing care for patients with NR, and health policy makers, particularly in countries with developing economies. Significant reductions in inter-laboratory variation in serum 25OHD are observed using LC-MS/MS with application of the NIST standard reference materials (SRMs).
Defining Nutritional
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Dietary calcium deficiency is diagnosed by obtaining a calcium intake history. As the sources of calcium will vary by country and region, we recommend that clinicians develop a dietary calcium intake questionnaire specific to their country/region.
Vitamin D Status
Recommendation:
 The panel recommends the following classification of vitamin D status, based on serum
Our definition of vitamin D deficiency in the context of skeletal mineralization and mineral ion metabolism for prevention of NR is based on strong evidence 1,2,24-27 supported by the increased incidence of NR with 25OHD concentrations <30 nmol/L (1 ng/mL=2.5 nmol/L). Our definition is consistent with that of The Institute of Medicine (IOM). 28 The potential health impacts of maintaining a serum concentration >50 nmol/L are beyond the scope of this review, and are addressed elsewhere. 29 It should be noted that NR has been reported in children with 25OHD concentrations >30 nmol/L 2,5,6,30 and that NR may not occur with very low 25OHD concentrations, but is more likely to occur with deficiency sustained over time i.e. chronic deficiency. The majority of children with vitamin D deficiency are asymptomatic 15 highlighting the interplay between serum 25OHD level and dietary calcium intake in maintaining serum calcium concentrations and bone integrity (Figure 1 ).
Although the most significant functional outcome of vitamin D deficiency is the development of osteomalacia and rickets, biochemical and bone density associations are also reported. Laboratory observations demonstrate that PTH increases when 25OHD levels drop below 34 nmol/L. 7 Moreover, all patients with rickets in that study had 25OHD levels less than 34 nmol/L and PTH was elevated in all but one patient. Taken together, the evidence suggests that a 25OHD level at 30-34 nmol/L may be the critical cut-off below which NR is more likely to occur.
Seasonal variations in 25OHD of between 13-24 nmol/L 31 emphasize the importance of maintaining 25OHD levels >50nmol/L (ie, sufficient), so as to prevent prolonged periods of 25OHD levels <30 nmol/L, with the risk of developing NR.
1.3.
Vitamin D Toxicity
Recommendation:
 Toxicity is defined as hypercalcaemia and serum 25OHD >250 nmol/L with hypercalciuria and suppressed PTH.
Intoxication is predominantly seen in infants and young children following exposure to high doses of vitamin D (240,000 to 4,500,000IU). [32] [33] [34] [35] [36] [37] High 25OHD concentrations can cause hypercalcaemia, When PTH assay is also unavailable, the possibility of toxicity should be considered in the presence of symptomatic hypercalcaemia in association with pharmacologic doses of vitamin D.
hypercalciuria and, if prolonged, nephrocalcinosis and renal failure. To allow a large safety margin, the consensus group felt it prudent to use the concentration of 250 nmol/L as the recommended upper limit of serum 25OHD -even if symptomatic toxicity from RCTs has only been reported at levels > 500 nmol/L. 32 In otherwise healthy infants, hypercalcaemia and hypercalciuria in the absence of elevated 25OHD
concentrations have been reported and may be related to genetic variation in vitamin D metabolism. o Sufficiency: > 500 mg/day o Insufficiency: 300-500 mg/day o Deficiency:
< 300 mg/day
Evidence
In developing countries where calcium intake is characteristically very low, with few or no dairy products, dietary calcium deficiency is the main cause of NR among children outside the infant age group.
In 2011, the IOM recommended adequate intakes of calcium (AI) for infants, children and adults. 16 The AI for infants was based on breast milk calcium content, which is 200 mg/day and 260 mg/day for babies from 0-6 and 6-12 months, respectively. For children 1-18 year of age, the IOM set the daily calcium requirement (RDA) at 700-1300 mg/day, depending on age. 28 There is, however, no true definition of dietary calcium deficiency without a reliable biomarker of calcium intake status and little data to indicate what the lowest calcium intake is that prevents NR. Reports from Nigeria, India and Bangladesh 6, 30, [40] [41] [42] [43] highlighted the role of low dietary calcium intake in the pathogenesis of NR among children. While some of these children also had suboptimal 25OHD, others had values >50 nmol/L which points to the interplay between calcium and vitamin D in the pathogenesis of NR (Figure 1 ). These studies suggest that in children >12 months of age, a dietary calcium intake of <300 mg/day significantly increases the risk of NR independent of serum 25OHD levels, and that at a daily intake of >500 mg, no NR was seen. 44 However, fractures only occurred in those who were mobile and had severe radiographic evidence of rickets. While none of the fractures were considered to be characteristic of non-accidental injury (child abuse), two infants had lateral or anterior-lateral rib fractures. In a national survey in Canada, 11 out of 108 cases of NR (11%) had suffered fractures, although details on the bone sites and numbers of fractures were not provided. 1 Fractures also have been reported in cases or case series of NR in toddlers and adolescents, [45] [46] [47] [48] [49] [50] but details about the number, site and type of fractures were absent.
It has been suggested that radiographic features of rickets may be mistaken for those characteristic of nonaccidental injury, 51, 52 but the necessary biochemical and radiographic data on the cases for validation of the authors' conclusions were absent. In addition, serum 25OHD levels are similar in infants with accidental and non-accidental injuries. 53 Thus, simple vitamin D deficiency, that is, vitamin D deficiency without biochemical or radiological signs of rickets, has not been associated with increased fracture risk in infants and children.
Prevention and Treatment of Nutritional Rickets and Osteomalacia
Vitamin D Supplementation for the Prevention of Rickets and Osteomalacia
Recommendations:
 400 IU/day (10µg) is adequate to prevent rickets and is recommended for all infants from birth to 12 months of age, independent of their mode of feeding. (1)
 Beyond 12 months of age, all children and adults need to meet their nutritional requirement for vitamin D through diet and/or supplementation, which is at least 600 IU/day (15µg), as recommended by the IOM. (1)
Evidence
Few published studies have included the prevention of radiographic or clinical signs of rickets as an outcome. Consequently, we also reviewed studies that assessed the effect of different vitamin D supplementation regimens † on 25OHD levels and other bone parameters (such as bone mineral density, BMD) with the goal of preventing rickets by maintaining levels above the rachitic range, ie >30 nmol/L. 54 In infants and children, 400 IU/d of vitamin D given as a supplement during infancy is sufficient to prevent radiographic signs of rickets in the short-term (up to 12 months). 54 Specifically, an RCT demonstrated that a vitamin D supplement of 400 IU/day was sufficient to prevent radiographic signs of rickets at 6 months of age, even among infants born with vitamin D deficiency. 25 Similarly, no cases of radiographically-confirmed rickets were seen following administration of 400 IU/day of vitamin D for 12 months, whereas the incidence was 3.8% in Turkish infants and young children who did not receive supplementation. 55 In addition, no incident cases of radiographically-confirmed rickets were reported in a two-year surveillance study of Canadian infants who received 400 IU/d of vitamin D. 1 Worldwide, there have been no reports of radiographically-confirmed rickets in infants or children receiving 400 IU on a regular, daily basis. Furthermore, this dose has been shown in RCTs to achieve 25OHD levels more frequently above the rachitic (severe deficiency) range compared to 100 or 200 IU/day. 25 The prevention of vitamin D deficiency in the absence of NR was also briefly reviewed. In a doubleblind RCT of infants without vitamin D deficiency (25OHD > 50 nmol/l), the impact of 400, 800, 1200
and 1600 IU of vitamin D 3 per day were assessed. 54 Doses of 400 IU/day maintained 25OHD levels >50 nmol/L in 97% of infants after 12 months; doses of 800 and 1200 IU/d were of no added benefit to BMD parameters, and 1600 IU/d raised concerns about potential toxicity. A study in infants with vitamin D deficiency (25OHD <25 nmol/L) found that a single dose of 100,000 IU maintained 25OHD levels above 37.5 nmol/L for 3 months without hypercalcemia, while higher doses led to unacceptably high 25OHD levels. 56 Among infants and toddlers with 25OHD levels <50 nmol/L for whom daily vitamin D supplementation may not be ideal, intermittent bolus doses of 50-100,000 IU 3-monthly hold promise, although a comprehensive understanding of the safety and efficacy of this approach remains to be studied. † Note that the term "supplementation" may be interpreted to mean additional vitamin D provided from supplements, general multivitamins, or food fortification. In the context of this article, Vitamin D supplementation refers to vitamin D above that which is found in standard dietary sources, with the exception of fortified infant formula.
Target for Vitamin D Supplementation
Recommendation:
Evidence
No studies have specifically examined the best monitoring approach once supplementation has been given to prevent vitamin D deficiency rickets. 25OHD is a reasonable monitoring parameter to ensure levels greater than 30-34 nmol/L for rickets prevention. Biochemically, a fall in 25OHD concentration <34 nmol/L is associated with rising PTH levels, but this intersection point depends on the prevailing calcium intake.
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The frequent co-existence of dietary calcium deficiency and vitamin D deficiency alters the threshold for rickets development. 57 Similarly, monitoring 25OHD concentrations as a public health policy for all individuals is impractical; fortunately, high risk groups can easily be identified based on clinical profile ( Table 2 ).
2.3.
Candidates for Preventative Vitamin D Supplementation beyond 12 months of age
Recommendations:
In the absence of food fortification, Vitamin D supplementation should be given to: Children with chronic illnesses and conditions affecting vitamin D synthesis/absorption/metabolism may also benefit from supplementation and may require higher doses, 58 but are not in the remit of this consensus on NR. with hypercalcaemia and/or hypercalciuria observed as a side effect only in a few individuals and usually seen in the 300,000-600,000 IU range. 64 In a small study of children with NR (n=17), doses of 1700-4000 IU of vitamin D 2 rapidly increased 25OHD concentrations within one week and normalized calcium, phosphate and ALP levels at 10 weeks. 65 Another study in children aged 2-36 months with NR (n=19), 5000 to 10,000 IU of oral vitamin D 3 and calcium 0.5 to 1.0g daily normalized serum PTH, calcium and phosphate within three weeks, although ALP levels remained elevated. 66 Simultaneous administration of calcium with vitamin D appears to be adequate and recommended by several studies. 67, 68 In 123 Nigerian children with NR due to calcium deficiency, the combined endpoint of an ALP level < 350 U/L and radiographic evidence of near complete healing of rickets was seen in a occasions over 3 months. 71 A higher proportion of subjects receiving oral treatment had 25OHD >75 nmol/l at 3 and 6 months than IM subjects.
Dose of Vitamin
One RCT in 61 children with NR compared a single IM dose of 600,000 IU vitamin D 3 to a weekly oral dose of 60,000 IU D 3 for 10 weeks. 72 There were no differences at 1, 4 and 12 weeks between groups in bone profiles, 25OHD concentrations or side effects. A meta-analysis of studies comparing the administration of vitamin D 2 and D 3 concluded that, when given as bolus doses, vitamin D 3 was more effective at raising 25OHD concentrations, but no significant differences were seen with daily doses. 73 There are no RCTs on the duration of treatment for children with NR and most of the literature consists of review articles. The review commissioned by the PES recommends that daily oral treatment be given for 8 to 12 weeks. 74 Similar durations between 8 and 12 weeks of daily treatment are recommended in reviews from the UK 75, 76 A duration of 3 months is recommended in a consensus statement from Australia and New Zealand. 77 Given the limited evidence, we recommend minimum treatment duration of 12 weeks to achieve a comprehensive healing and normalization of ALP, recognizing that some children may require longer treatment.
Several studies explored the concept of "stoss therapy" ie, the administration of a large dose given as a single or in divided doses over several days. This approach has been advocated for ease of use and compliance with therapy. Three different single oral doses (150,000 IU, 300,000 IU, or 600,000 IU) in 56
Turkish children aged 3-36 months with NR did not affect the rate of improvement of rickets at 30 days. 64 However, eight subjects (2 in 300,000 IU group, 6 in the 600,000 IU group) developed hypercalcaemia. A recent study in India compared single oral doses of 300,000 versus 600,000 IU of vitamin D 3 in 76 rachitic children aged 6 months to 5 years. 78 At 12 weeks, all children demonstrated radiographic healing with comparable decreases in ALP and PTH. However, hypercalcaemia occurred in five children (6.5%) -2 receiving 300,000 IU and 3 receiving 600,000 IU. Several review articles advocate different recommendations with "stoss therapy" that are not supported by evidence. [75] [76] [77] The few studies comparing daily treatment to "stoss therapy" contained groups with different subject characteristics. Although we recommend daily treatment as the first line of management, we recognize that in some situations, "Stoss therapy" may be more practical. Therefore, we provide vitamin D dose recommendations for both treatment options ( Table 3) . Any treatment needs to be followed by supplementation (see 2.1 and 2.3). In a Canadian case series, 6 First Nation infants presented with hypocalcaemic seizures within the first 30 days of life, with suspected or confirmed maternal vitamin D deficiency and a lack of supplementation during pregnancy. 86 All were formula fed, which suggests that although their intake of vitamin D would have been sufficient in normal circumstances, in these infants the oral vitamin D supply via formula milk was insufficient to treat their pre-existing severe neonatal deficiency.
Prevention of
Prevention of maternal deficiency is critical and all mothers should meet their nutritional requirement for vitamin D, which is currently set at 600 IU/d, although this value is not based on direct evidence from
RCTs of vitamin D supplementation in pregnant women. 28 Potentially, a higher intake of vitamin D may be required to prevent both maternal and neonatal deficiency. 87 Prevention of congenital vitamin D deficiency is described in section 4.4. 
Early Feeding
Evidence
There is abundant yet low quality evidence from multiple case reports, case series, 11, 48, 49, 88 well as personal factors such as occupation, lifestyle, culture such as clothing, and preference which may modify time spent outdoors and/or the surface area of skin exposed to sunlight. [130] [131] [132] [133] Finally, the doseresponse of circulating 25OHD to cutaneous UVB exposure is dependent on skin pigmentation, age, body composition, genetic factors, and baseline 25OHD levels, among others. 121, 131, [134] [135] [136] [137] [138] Abundant global observational data report an association between restricted epidermal exposure and NR as a consequence of vitamin D deficiency. 85, [139] [140] [141] [142] [143] Ultraviolet radiation (UVR) causes skin cancer, and exposure to UVR from sunlight and artificial sources early in life elevates the risk of developing skin cancer. 144 Without firm evidence to account for variations in age, skin color, latitude, time of day and time of year it is currently impractical to provide prescriptive advice on safe solar exposure to the population as a whole. All risk factors are summarized in Table 2 . 
Prevention of Osteomalacia during Pregnancy and Lactation and Congenital
Evidence
There is moderate evidence that low maternal vitamin D status during pregnancy is associated with elevated cord blood ALP and larger fontanelle size at birth. 145, 146 Moderate to strong evidence from two RCTs, 145, 147 two controlled trials, 148, 149 and one observational study 150 indicated that low maternal vitamin D status during pregnancy increases risk of neonatal hypocalcaemia; however, a smaller RCT and a controlled trial did not support these findings. 146, 151 A single large controlled trial suggests that vitamin D supplementation during pregnancy improves dental enamel formation of offspring. 148 There are conflicting data about the association between maternal vitamin D status during pregnancy and birth anthropometry. Three RCTs of moderate to high quality using daily dose or single high-dose regimens did not find an association [151] [152] [153] while two controlled trials of moderate grade evidence found a positive association. 146, 147 Three low to high-quality RCTs did not find any difference in birth anthropometry in offspring of mothers supplemented with either 400, 2000 or 4000 IU per day; none of the studies had a placebo group. 87, 154, 155 There are inconsistent data on the association between maternal serum 25OHD levels and linear growth during the first year of life 152, 156, 157 and insufficient to weak evidence for an association between maternal serum 25OHD levels and bone mass or density at birth, 150, [158] [159] [160] [161] or in later childhood.
162-164
Effect of Calcium Supplementation during Pregnancy on Infant Bone Mass
Recommendation:
 Pregnant women do not need calcium intakes above recommended non-pregnant intakes to improve neonatal bone. (1)
Evidence
Calcium supplementation studies in pregnancy have not had congenital or neonatal rickets as an outcome, but three RCTs of maternal calcium supplementation during pregnancy measured neonatal bone. [165] [166] [167] These RCTs were conducted in West Africa where typical dietary calcium intakes are 250-300 mg/day, 165 in the US with an average intake of about 2000 mg/day, 166 and in a multicentre WHO study in populations with dietary calcium intake of ~600 mg/day (Argentina, Peru, India, Egypt, Vietnam, South Africa). 167 Maternal calcium supplementation had no effect on neonatal bone mineral assessed by DXA in the Gambian and US studies, except in the latter study in offspring of women in the lowest quintile of dietary calcium intake (<600 mg/day). There was no effect of maternal calcium supplementation on neonatal or infant anthropometry, a finding consistent with observational studies. 
Influence of Calcium or Vitamin D Supplementation in Pregnancy or
168-171
Supplementing mothers with high amounts of vitamin D has been suggested as a means of increasing both maternal (Figure 3 ) and infant serum 25OHD concentrations. [172] [173] [174] [175] Maternal vitamin D intakes up to 4,000 IU/day are likely safe during pregnancy and lactation. 16 However, the finding that infants of Maternal calcium intake during pregnancy or lactation does not influence breast milk calcium concentrations. Only one observational study found a weak association between maternal calcium intakes during pregnancy and breast milk calcium level at day 40 (mature milk). 176 Numerous studies, including two RCTs 177, 178 and two observational studies 179, 180 have not found a relationship between maternal calcium intake and breast milk calcium concentrations. 
Evidence
Rickets has been increasingly reported in high and low income countries. 55, [209] [210] [211] [212] [213] Using different methodology, the incidence of NR has been reported as 2.9, 4.9, 7.5, and 24 per 100.000 in Canada, 1 Australia, 2 UK, 3 and the USA, 99 respectively. Many studies are hospital based but provide additional insight into the burden of NR. Infants with NR may present with hypocalcaemic seizures. The incidence of dilated cardiomyopathy associated with NR and hypocalcemia is unknown, but it is potentially the deadliest and most economically costly complication of NR. 11 The methods used for the diagnosis of NR in case reports 102 and small to large case series 104, [214] [215] [216] [217] are widely variable and many lack radiographic confirmation. 209 Physician-based surveys can estimate the burden of disease, but few have been done.
1,2
Population-based studies provide the most accurate assessment of the disease burden. 3, 99, 211, [218] [219] [220] [221] Despite differing methodologies, published reports indicate the greatest burden of NR is in Africa, Asia, and the Middle East due to sun avoidance or dietary calcium insufficiency. 209, 213 Even high-income countries have observed a resurgence of NR, mainly among immigrants of African, Asian or Middle-Eastern origin. This overall increase in the incidence of NR in high-income countries corresponds to an increase in the numbers of individuals in ethnic minority, immigrant, and refugee groups. [1] [2] [3] [4] 99, 222 The incidence among established Caucasian populations is stable or decreasing. In regions with a low prevalence of NR, inclusion of NR as a reportable disease is potentially the most cost-effective means of case identification and surveillance. 1, 2, 4, 99, 222 Measurement of serum 25OHD is useful for the diagnosis of vitamin D deficiency in NR, but not for population screening. 223, 224 Raised serum ALP has been used as a screening tool for NR. 225 However, acute illness, drugs, liver disease, growth spurts, and transient hyperphosphatasaemia of infancy and childhood can all elevate ALP values. Because of the invasiveness of venipuncture, high cost, and low positive predictive values, serum ALP and 25OHD cannot be recommended for population screening.
Although radiographs of the wrists and knees provide definitive confirmation of active rickets, 226 radiation exposure precludes recommending screening radiographs in asymptomatic children. 
Public Health Strategies for
227,228
Food fortification with vitamin D 234 Fortification of chupatty flour (6000 IU/kg) raised 25OHD from ≈12.5nmol/l to ≈48 nmol/l in children over a 6 month period. India. 237 Fortification and supplementation requirements may vary with population exposure to sunshine (see section 3). 238 
Food fortification with calcium
Inadequate dietary calcium intake is a risk factor for NR in children over the age of 12 months with low dairy product intake, a common situation in low income countries. The IOM recommends a calcium intake of 500 mg/d in children ages 1-3 years when children are at the greatest risk of nutritional rickets, based on calcium retention in absorption studies. 16 In populations with low dairy intake such as in Africa and parts of Asia, indigenous food sources of calcium or fortification of staple foods with calcium can provide adequate calcium intake in children. 213, 239 Calcium salts can be used to fortify infant formulas, complementary foods, and staple food in areas where dairy intake is low. Calcium carbonate for food fortification is available at very low cost.
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Food fortification effectively increased dietary calcium intakes by using calcium fortified laddoos in the diet of underprivileged Indian toddlers, 240 and by calcium fortification of cereal for 7-12 year old children. 241 More than 1100 foods are calcium fortified in the US, yet dairy food makes up more than 65% of adolescents' calcium intake. 242 In the UK, calcium fortification of flour is an important source of calcium intake (16% of total) for young adolescent girls. 243 There are limited data from studies on calcium fortification or the acceptability of dietary diversification to include locally available and affordable calcium-rich foods in developing countries. Periodic monitoring for NR is important to determine the effectiveness of fortification and /or supplementation programs in preventing NR.
Health Promotion
Education of medical providers and organizations, health insurers, policy makers, governments, public health officials and the general public is vital to address the public health issue of rickets and vitamin D deficiency. They should be provided with guidelines on the importance of adequate vitamin D and calcium intakes in children, adolescents, pregnant, and lactating women. 244 National and global public health promotion strategies are essential to raise professional and community awareness, and global action to protect all children from vitamin D and calcium deficiency is imperative.
Economic Cost/Benefits of Prevention Programs
Recommendation:
 The cost-effectiveness of supplementation and food fortification programs needs further study.
(1)
Evidence
Very weak evidence supports a policy of providing vitamin D supplementation to Asian children in the UK for the first two years of life. 245 Costs of vitamin D supplementation and/or fortification programs will differ depending on the target 25OHD level and population characteristics. Subgroup analyses targeting high risk groups, such as people with darkly pigmented skin, limited sun exposure, and low calcium intakes, should be conducted.
Conclusion
Vitamin D deficiency should be considered a major global public health priority. NR can have severe consequences, including death from cardiomyopathy or obstructed labor, myopathy, seizures, pneumonia, lifelong deformity and disability, impaired growth, and pain. Rickets is the "the tip of the iceberg," and its Reassess response to treatment after 3 months as further treatment may be required.
Ensure a daily calcium intake of at least 500mg
For conversion from IU to µg, divide by 40.
